S. Houng

发表

Synthesis and characterization of folate-PEG-conjugated polysaccharide nanoparticles for potential use as a targeted DNA carrier

S. Houng, 2009 .

C/ebp␣ and C/ebp␣ Oncoproteins Regulate Nfkb1 and Displace Histone Deacetylases from Nf-␬b P50 Homodimers to Induce Nf-␬b Target Genes

A. Friedman, S. Houng, I. Paz‐Priel, 2022 .

Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma

K. Mazan-Mamczarz, K. Becker, S. Efroni, 2015, Cell Communication and Signaling.

Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders

K. Mazan-Mamczarz, K. Becker, R. Talwani, 2015, Oncogene.

Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.

S. Houng, F. Veiga, R. Neufeld, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65, Focusing Therapeutic Targeting on the C/EBP:p50 Interaction

A. Baldwin, A. Friedman, S. Houng, 2011, Molecular Cancer Research.

Article title: Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase

K. Mazan-Mamczarz, S. Shackelford, R. Tesoriero, 2017 .

LYMPHOID NEOPLASIA Inhibiting CARD 11 translation during BCR activation by targeting the eIF 4 A RNA helicase

S. Shackelford, R. Tesoriero, T. Scalea, 2014 .

title : Inhibiting CARD 11 translation during BCR activation by targeting the eIF 4 A RNA helicase Short title : BCR activation enhances eIF 4 A activity

S. Shackelford, R. Tesoriero, T. Scalea, 2014 .

MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL

K. Mazan-Mamczarz, K. Becker, K. Borden, 2014, Nature Communications.

Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma

K. Becker, S. Efroni, R. Gartenhaus, 2015, Cell Communication and Signaling.

C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65, Focusing Therapeutic Targeting on the C/EBP:p50 Interaction

A. Baldwin, A. Friedman, S. Houng, 2011, Molecular Cancer Research.

C/EBPα and C/EBPα oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genes.

A. Friedman, S. Houng, I. Paz‐Priel, 2011, Blood.

C/EBP (cid:1) and C/EBP (cid:1) oncoproteins regulate nfkb1 and displace histone deacetylases from NF- (cid:2) B p50 homodimers to induce NF- (cid:2) B target genes

S. Houng, I. Paz‐Priel, J. Dooher, 2011 .